Objective:

To investigate ACOD1 expression levels in sepsis patients and their correlation with disease severity and immune profiles, highlighting its potential significance as a biomarker.

Key Findings:

• ACOD1 expression levels were significantly higher in sepsis patients compared to healthy controls (p < 0.05).
• High ACOD1 expression correlated with increased SOFA scores and DIC scores, indicating greater disease severity (r = 0.65, p < 0.01).
• Differentially expressed genes associated with ACOD1 were linked to immune response and metabolic pathways, suggesting a broader impact on sepsis pathology.

Interpretation:

The findings suggest that ACOD1 may serve as a potential biomarker for sepsis severity and could influence immune homeostasis in septic patients, warranting further investigation into its clinical applications.

Limitations:

• Study relies on publicly available datasets, which may have inherent biases, such as selection bias and batch effects.
• Correlation does not imply causation; further functional studies are needed to establish direct effects of ACOD1 on immune responses.

Conclusion:

ACOD1 levels are associated with sepsis severity and immune profiles, highlighting its potential role in sepsis management and research, and underscoring the need for further studies to validate these findings.